Perspective Therapeutics to Showcase Cancer Pipeline at Major Spring Biopharma Events
Perspective Therapeutics will present at two major investor conferences in April 2026, highlighting its alpha-emitting radiopharmaceutical pipeline for oncology.
CATXclinical trialscancer treatment